Trials / Completed
CompletedNCT00180284
SITELINE 2 Polyurethane
SITELINE 2 Polyurethane Clinical Investigation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The SITELINE 2 Polyurethane Clinical Investigation analyzed the safety and electrical performance of the SITELINE 2 Polyurethane pacing lead.
Detailed description
This was a prospective, single-arm, multi-center U.S. clinical investigation, designed to demonstrate the safety and effectiveness of the SITELINE 2 Polyurethane extendable, retractable pacing lead in humans
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SITELINE 2 Polyurethane (pacing lead) | SITELINE 2 Polyurethane (pacing lead) |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2005-05-01
- Completion
- 2008-02-01
- First posted
- 2005-09-16
- Last updated
- 2011-09-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00180284. Inclusion in this directory is not an endorsement.